chloroquine has been researched along with Porphyria in 116 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Longer remissions after the phlebotomy therapy than after the low-dose chloroquine treatment were ascertained by means of the long-term follow-up of a large group of porphyria cutanea tarda patients." | 9.05 | A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda. ( Chlumský, J; Malina, L, 1981) |
| "We report a 33-year-old female patient who had hemodialysis-associated pseudoporphyria which did not respond to treatment with oral N-acetylcysteine." | 7.77 | Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine. ( Alouane, Z; Bahadi, A; El Kabbaj, D; Laalou, A; Oualim, Z, 2011) |
| "In 59 patients showing clear clinical and biochemical signs of porphyria cutanea tarda (PCT), we tested 3 different modes of therapy: 20 patients received combined treatment with repeated bleeding and chloroquine, 24 patients were exclusively treated with oral chloroquine in low doses, and 15 patients underwent repeated phlebotomy only." | 7.68 | [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]. ( Batlle, A; Guzman, H; Seubert, A; Seubert, S; Stella, AM, 1990) |
| "The knowledge about the influence of chloroquine phosphate (CQ) on the iron metabolism in porphyria cutanea tarda (PCT) is still insufficient." | 7.68 | [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda]. ( Köstler, E; Pollack, P; Riedel, H; Seebacher, C, 1990) |
| "Seven patients with porphyria cutanea tarda received a total of ten courses of low-dose oral chloroquine therapy (125 mg chloroquine phosphate twice weekly)." | 7.67 | Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. ( Ashton, RE; Hawk, JL; Magnus, IA, 1984) |
| "Forty-six patients with porphyria cutanea tarda were observed for a mean period of 32 months (range 4-86) after treatment with high-dose, short-course chloroquine phosphate." | 7.67 | Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda. ( Tsega, E, 1987) |
| "Treatment of a six-year-old boy with porphyria congenita (Günther) by small amounts of chloroquine was followed by a sharp but transient increase of the urinary excretion of porphyrins." | 7.66 | [Porphyria erythropoietica congenita Günther and chloroquine (author's transl)]. ( Ippen, H; Seubert, A; Seubert, S; Tillmann, W, 1978) |
| "Treatment of a patient with porphyria cutanea tarda with low dose chloroquine improved the clinical and biochemical abnormalities in association with a reduction in photosensitivity as shown by changes in the action spectrum." | 7.66 | Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine. ( Gould, P, 1978) |
| "The treatment of Porphyria Cutaneous Tarda (PCT) has greatly improved by the introduction of low-dose chloroquine." | 7.66 | [Effect of chloroquine in porphyria cutanea tarda]. ( Herrero, C; Muniesa, A, 1980) |
| "In thirty-four patients with porphyria cutanea tarda treated with small doses of chloroquine, liver biopsies were performed before and after treatment." | 7.66 | Liver changes in porphyria cutanea tarda patients treated with chloroquine. ( Chlumska, A; Chlumsky, J; Malina, L, 1980) |
| "Intermittent chloroquine medication was given to 15 patients with porphyria cutanea tarda." | 7.66 | [Treatment of porphyria cutanea tarda with intermittent chloroquine]. ( Formanek, I; Raff, M, 1980) |
| "Treatment of porphyria cutanea tarda (PCT) with chloroquine risks serious side-effects so we have combined it with phlebotomy." | 7.65 | Treatment of porphyria cutanea tarda with chloroquine and phlebotomy. ( Swanbeck, G; Wennersten, G, 1977) |
| "She was being treated for porphyria cutanea tarda (p." | 5.27 | [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda]. ( Drasch, G; Eisenmenger, W, 1986) |
| " After treatment with Resochin in an erroneously high dosage (1." | 5.26 | [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)]. ( Eichenauer, MG; Goerz, G; Krieg, T, 1976) |
| "Longer remissions after the phlebotomy therapy than after the low-dose chloroquine treatment were ascertained by means of the long-term follow-up of a large group of porphyria cutanea tarda patients." | 5.05 | A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda. ( Chlumský, J; Malina, L, 1981) |
| " Porphyria cutanea tarda can be effectively treated by phlebotomy or low dose chloroquine." | 4.81 | Management of acute and cutaneous porphyrias. ( Badminton, MN; Elder, GH, 2002) |
| "We report a 33-year-old female patient who had hemodialysis-associated pseudoporphyria which did not respond to treatment with oral N-acetylcysteine." | 3.77 | Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine. ( Alouane, Z; Bahadi, A; El Kabbaj, D; Laalou, A; Oualim, Z, 2011) |
| "Five patients with porphyria cutanea tarda (PCT) were treated with a prolonged, low-dose chloroquine regimen (250 mg twice weekly)." | 3.68 | Skin morphology in porphyria cutanea tarda does not improve despite clinical remission. ( Mustajoki, P; Niemi, KM; Timonen, K, 1991) |
| "The knowledge about the influence of chloroquine phosphate (CQ) on the iron metabolism in porphyria cutanea tarda (PCT) is still insufficient." | 3.68 | [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda]. ( Köstler, E; Pollack, P; Riedel, H; Seebacher, C, 1990) |
| "In 59 patients showing clear clinical and biochemical signs of porphyria cutanea tarda (PCT), we tested 3 different modes of therapy: 20 patients received combined treatment with repeated bleeding and chloroquine, 24 patients were exclusively treated with oral chloroquine in low doses, and 15 patients underwent repeated phlebotomy only." | 3.68 | [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]. ( Batlle, A; Guzman, H; Seubert, A; Seubert, S; Stella, AM, 1990) |
| "A 56-year-old patient suffering from porphyria cutanea tarda (PCT) was sufficiently treated with chloroquine and occasional bleeding." | 3.68 | [Artefacts in porphyria cutanea tarda]. ( Egger, B; Goerz, G, 1990) |
| "Seven patients with porphyria cutanea tarda received a total of ten courses of low-dose oral chloroquine therapy (125 mg chloroquine phosphate twice weekly)." | 3.67 | Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. ( Ashton, RE; Hawk, JL; Magnus, IA, 1984) |
| "Seventy-three patients with porphyria cutanea tarda (PCT) were treated with chloroquine phosphate, which was administered in doses of 250 mg twice a week for more than 1 year on average." | 3.67 | [Therapeutic and pathogenetic aspects of porphyria cutanea tarda]. ( Kemmer, C; Köstler, E; Riedel, H; Seebacher, C, 1986) |
| "Forty-six patients with porphyria cutanea tarda were observed for a mean period of 32 months (range 4-86) after treatment with high-dose, short-course chloroquine phosphate." | 3.67 | Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda. ( Tsega, E, 1987) |
| "Rats were treated with the well-known porphyrogen hexachlorobenzene (HCB) to induce experimental porphyria." | 3.67 | Influence of chloroquine on the porphyrin metabolism. ( Bolsen, K; Goerz, G; Merk, H, 1985) |
| "A female patient with porphyria cutanea tarda (PCT) clinically cured by a low-dose chloroquine treatment showed neither exacerbation of the disease nor an increased excretion of urinary porphyrins during pregnancy." | 3.66 | Porphyria cutanea tarda and pregnancy. ( Goerz, G; Hammer, G, 1983) |
| "The treatment of Porphyria Cutaneous Tarda (PCT) has greatly improved by the introduction of low-dose chloroquine." | 3.66 | [Effect of chloroquine in porphyria cutanea tarda]. ( Herrero, C; Muniesa, A, 1980) |
| "Treatment of a six-year-old boy with porphyria congenita (Günther) by small amounts of chloroquine was followed by a sharp but transient increase of the urinary excretion of porphyrins." | 3.66 | [Porphyria erythropoietica congenita Günther and chloroquine (author's transl)]. ( Ippen, H; Seubert, A; Seubert, S; Tillmann, W, 1978) |
| "Treatment of a patient with porphyria cutanea tarda with low dose chloroquine improved the clinical and biochemical abnormalities in association with a reduction in photosensitivity as shown by changes in the action spectrum." | 3.66 | Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine. ( Gould, P, 1978) |
| " The treatment of porphyria cutanea tarda with chloroquine shows good success." | 3.66 | [Modern internal therapy of skin diseases (author's transl)]. ( Goerz, G, 1979) |
| "Intermittent chloroquine medication was given to 15 patients with porphyria cutanea tarda." | 3.66 | [Treatment of porphyria cutanea tarda with intermittent chloroquine]. ( Formanek, I; Raff, M, 1980) |
| "In thirty-four patients with porphyria cutanea tarda treated with small doses of chloroquine, liver biopsies were performed before and after treatment." | 3.66 | Liver changes in porphyria cutanea tarda patients treated with chloroquine. ( Chlumska, A; Chlumsky, J; Malina, L, 1980) |
| "The effect of ethanol, phenobarbitone, griseofulvin or chloroquine on 3,4-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced porphyria in rats has been studied in experiments lasting up to 40 days." | 3.65 | Study of the effects of certain drugs on experimental porphyria in rats. ( Bhutani, LK; Bikhchandani, R; Deshpande, SG; Kandhari, KC; Narang, BS, 1977) |
| "Treatment of porphyria cutanea tarda (PCT) with chloroquine risks serious side-effects so we have combined it with phlebotomy." | 3.65 | Treatment of porphyria cutanea tarda with chloroquine and phlebotomy. ( Swanbeck, G; Wennersten, G, 1977) |
| "The porphyrias are caused by hereditary defects in the synthesis of heme." | 1.27 | The porphyrias. ( Rosen, T; Sekula, SA; Tschen, JA, 1986) |
| "She was being treated for porphyria cutanea tarda (p." | 1.27 | [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda]. ( Drasch, G; Eisenmenger, W, 1986) |
| " After treatment with Resochin in an erroneously high dosage (1." | 1.26 | [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)]. ( Eichenauer, MG; Goerz, G; Krieg, T, 1976) |
| "Diabetes mellitus was found in 15%; systemic lupus erythematosus in 5%; elevated serum iron level in 62%; and, abnormal liver function test results in 60%." | 1.26 | Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. ( Bickers, DR; Deleo, VA; Grossman, ME; Harber, LC; Poh-Fitzpatrick, MB, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 108 (93.10) | 18.7374 |
| 1990's | 6 (5.17) | 18.2507 |
| 2000's | 1 (0.86) | 29.6817 |
| 2010's | 1 (0.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Kabbaj, D | 1 |
| Laalou, A | 1 |
| Alouane, Z | 1 |
| Bahadi, A | 1 |
| Oualim, Z | 1 |
| LINDEN, IH | 1 |
| STEFFEN, CG | 1 |
| NEWCOMER, VD | 1 |
| CHAPMAN, M | 1 |
| DAVIS, MJ | 1 |
| PLOEG, DE | 1 |
| LONDON, ID | 1 |
| MARSDEN, CW | 1 |
| GROGG, E | 1 |
| MACAULAY, WL | 1 |
| EMBREE, PW | 1 |
| BELUKHA, UK | 1 |
| RIMINGTON, C | 1 |
| HAMAGUCHI, T | 1 |
| KOTANI, Y | 1 |
| ISHIBUCHI, M | 1 |
| ZIEKUR, U | 1 |
| SWEENEY, GD | 3 |
| SAUNDERS, SJ | 1 |
| DOWDLE, EB | 1 |
| EALES, L | 1 |
| Riedel, H | 4 |
| Justus, J | 1 |
| Köstler, E | 5 |
| Pätzold, K | 2 |
| Kemmer, C | 2 |
| Cramers, M | 1 |
| Jepsen, LV | 1 |
| Malina, L | 6 |
| Chlumský, J | 4 |
| Goerz, G | 12 |
| Strohmeyer, G | 1 |
| Ashton, RE | 1 |
| Hawk, JL | 1 |
| Magnus, IA | 1 |
| Bidrat, MS | 1 |
| Montag, H | 1 |
| Schmeel, A | 1 |
| Seebacher, C | 3 |
| Bässler, E | 1 |
| Stölzel, U | 1 |
| Michel, B | 1 |
| Guillot, B | 1 |
| Guilhou, JJ | 1 |
| Meynadier, J | 1 |
| Chinarro, S | 1 |
| de Salamanca, RE | 1 |
| Perpiñá, J | 1 |
| Muñoz, JJ | 1 |
| Peña, ML | 1 |
| Idel'son, LI | 1 |
| Hammer, G | 1 |
| Wennersten, G | 2 |
| Ros, AM | 1 |
| Tanenbaum, L | 1 |
| Tuffanelli, DL | 1 |
| Herrero, C | 1 |
| Muniesa, A | 1 |
| Krivosheev, BN | 1 |
| Martásek, P | 3 |
| Jirsa, M | 5 |
| Kordac, V | 10 |
| Tsega, E | 3 |
| Damtew, B | 2 |
| Landells, JW | 2 |
| Besrat, A | 2 |
| Seyoum, E | 2 |
| Holvay, E | 2 |
| Anderson, PC | 2 |
| Kaláb, M | 4 |
| Semrádová, M | 4 |
| Papezová, R | 2 |
| Soldátová, H | 3 |
| Błaszczyk, M | 1 |
| Daoud, S | 1 |
| Chorzelski, T | 1 |
| Jabłońska, S | 1 |
| Sulej, J | 1 |
| Chlumska, A | 2 |
| Vizethum, W | 1 |
| Bolsen, K | 3 |
| Simon, K | 1 |
| Weber, K | 1 |
| Horkay, I | 2 |
| Nagy, E | 2 |
| Gerwel, M | 1 |
| Raff, M | 1 |
| Formanek, I | 1 |
| Badminton, MN | 1 |
| Elder, GH | 1 |
| Krieg, T | 2 |
| Finnerty, EF | 1 |
| Muhlbauer, JE | 1 |
| Pathak, MA | 1 |
| Jones, KG | 1 |
| Grossman, ME | 1 |
| Bickers, DR | 1 |
| Poh-Fitzpatrick, MB | 1 |
| Deleo, VA | 1 |
| Harber, LC | 1 |
| Dobiás, J | 1 |
| Gould, P | 1 |
| Ippen, H | 1 |
| Tillmann, W | 1 |
| Seubert, S | 2 |
| Seubert, A | 2 |
| Fromke, VL | 1 |
| Bossenmaier, I | 1 |
| Cardinal, R | 1 |
| Watson, CJ | 1 |
| Mathews-Roth, MM | 1 |
| Sams, WM | 1 |
| Roller, JA | 1 |
| Deshpande, SG | 1 |
| Kandhari, KC | 1 |
| Narang, BS | 1 |
| Bikhchandani, R | 1 |
| Bhutani, LK | 1 |
| Marecek, Z | 2 |
| Hunter, GA | 3 |
| Donald, GF | 3 |
| Swanbeck, G | 1 |
| Thornsvard, CT | 1 |
| Guider, BA | 1 |
| Kimball, DB | 1 |
| Jaschke, E | 1 |
| Kowertz, MJ | 2 |
| Eichenauer, MG | 1 |
| Adjarov, D | 1 |
| Kerimova, M | 1 |
| Timonen, K | 1 |
| Niemi, KM | 1 |
| Mustajoki, P | 1 |
| Pollack, P | 1 |
| Ginsburg, AD | 1 |
| Margesson, LJ | 1 |
| Feleki, K | 1 |
| Stella, AM | 2 |
| Guzman, H | 1 |
| Batlle, A | 1 |
| Egger, B | 1 |
| Heinicke, HJ | 1 |
| Schneider, F | 1 |
| Hensel, J | 1 |
| Kotal, P | 2 |
| Doss, MO | 1 |
| Enríquez de Salamanca, R | 1 |
| Cervinka, J | 1 |
| Papezová, P | 1 |
| Sekula, SA | 1 |
| Tschen, JA | 1 |
| Rosen, T | 1 |
| Battle, AM | 1 |
| De Kaminsky, AR | 1 |
| Kaminsky, C | 1 |
| Mariano, HG | 1 |
| Drasch, G | 1 |
| Eisenmenger, W | 1 |
| Seuwen, P | 1 |
| Schmitter, H | 1 |
| Merk, H | 2 |
| Lissner, R | 1 |
| Goh, CL | 1 |
| Zoubek, V | 1 |
| Handa, F | 1 |
| Walia, RL | 1 |
| Sadana, JK | 1 |
| Gill, BS | 1 |
| Tamayo, L | 1 |
| Ruiz-Maldonado, R | 1 |
| Ridaura, C | 1 |
| Meurer, M | 1 |
| Schulte, C | 1 |
| Weiler, A | 1 |
| Reed, WB | 1 |
| Howard, HF | 1 |
| Knutsson, F | 1 |
| Lindstedt, G | 1 |
| Norrby, A | 1 |
| Rödjer, S | 1 |
| Taljaard, JJ | 2 |
| Shanley, BC | 2 |
| Joubert, SM | 2 |
| Deppe, WM | 2 |
| Scholnick, PL | 1 |
| Epstein, J | 1 |
| Marver, HS | 1 |
| Copeman, PW | 1 |
| Beritić, T | 1 |
| Prpić-Majić, D | 1 |
| Roman, W | 1 |
| Taylor, AE | 1 |
| Stewart-Wynne, EG | 1 |
| Snitker, G | 1 |
| Hoo, TT | 1 |
| Vogler, WR | 1 |
| Galambos, JT | 1 |
| Olansky, S | 1 |
| Saltzer, EI | 1 |
| Redeker, AG | 2 |
| Wilson, JW | 1 |
| Bloom, M | 1 |
| Felsher, BF | 1 |
10 reviews available for chloroquine and Porphyria
| Article | Year |
|---|---|
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hemat | 1980 |
Management of acute and cutaneous porphyrias.
Topics: Arginine; beta Carotene; Chloroquine; Estrogens; Ethanol; Heme; Humans; Phlebotomy; Porphyria Cutane | 2002 |
Porphyria cutanea tarda.
Topics: Adolescent; Aged; Alcoholism; Animals; Chick Embryo; Child; Chloroquine; Diagnosis, Differential; He | 1979 |
Therapy of human photosensitivity.
Topics: Administration, Oral; Administration, Topical; Adult; Aminobenzoates; Benzophenones; Carotenoids; Ch | 1975 |
Chloroquine: its therapeutic use in photosensitive eruptions.
Topics: Antimalarials; Child, Preschool; Chloroquine; Female; Fetal Diseases; Humans; Lupus Erythematosus, D | 1976 |
[Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
Topics: Chloroquine; Humans; Liver Diseases; Porphyrias; Skin Diseases | 1988 |
[Porphyria hepatocutaneous tarda. Etiopathogenesis and physiopathologic treatment].
Topics: Chloroquine; Humans; Liver Diseases; Plasma Exchange; Porphyrias; Porphyrins; Skin Diseases | 1987 |
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
Topics: Animals; Bloodletting; Carboxy-Lyases; Chloroquine; Chromatography, High Pressure Liquid; Disease Mo | 1986 |
Chloroquine.
Topics: Abnormalities, Drug-Induced; Animals; Ascorbic Acid; Child; Chloroquine; Enzymes; Eye Diseases; Fema | 1967 |
[Porphyrias].
Topics: Acute Disease; Adenine Nucleotides; Chelating Agents; Chloroquine; Cholestyramine Resin; Chronic Dis | 1969 |
3 trials available for chloroquine and Porphyria
| Article | Year |
|---|---|
A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
Topics: Adult; Aged; Bloodletting; Chloroquine; Female; Humans; Liver; Male; Middle Aged; Porphyrias; Recurr | 1981 |
[Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
Topics: Adult; Aged; Chloroquine; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Middle | 1981 |
[Antimalarials in the treatment of porphyria cutanea tarda].
Topics: Adult; Chloroquine; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Long-Term Care; Male; | 1973 |
103 other studies available for chloroquine and Porphyria
| Article | Year |
|---|---|
Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Adult; Chloroquine; Drug Resistance; Female; Humans; Kidney Fa | 2011 |
Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus.
Topics: Chloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Porphyrias | 1954 |
Acute porphyria and coproporphyrinuria following chloroquine therapy; a report of two cases.
Topics: Chloroquine; Coproporphyria, Hereditary; Humans; Porphyria, Acute Intermittent; Porphyrias; Porphyri | 1957 |
Porphyria cutanea tarda; report of case successfully treated with chloroquine.
Topics: Animals; Chloroquine; Humans; Porifera; Porphyria Cutanea Tarda; Porphyrias; Skin Diseases | 1957 |
Porphyria during chloroquine therapy.
Topics: Chloroquine; Lupus Erythematosus, Systemic; Porphyrias | 1959 |
[On the drug modification of experimental porphyria in rabbits].
Topics: Animals; Ascorbic Acid; Chloroquine; Lagomorpha; Porphyrias; Rabbits; Thyroxine; Vitamins | 1960 |
Relapses of porphyria induced by chloroquine (aralen) phosphate; report of a case.
Topics: Chloroquine; Humans; Minnesota; Phosphates; Porphyrias; Recurrence | 1960 |
Porphyria in the Bantu and some observations on the effect of chloroquine.
Topics: Animals; Black People; Chloroquine; Humans; Porifera; Porphyrias | 1961 |
[THERAPEUTIC EFFECTIVENESS OF SOME DRUG SUBSTANCES AND THE CONTENT OF WATER-SOLUBLE VITAMINS IN PATIENTS WITH PHOTODERMATOSES].
Topics: Chloroquine; Eczema; Humans; Niacin; Nicotinic Acids; Photosensitivity Disorders; Porphyrias; Prurig | 1964 |
ENZYMES AND DRUG SENSITIVITY. DRUG AND ENZYME INTERACTIONS IN PORPHYRIAS.
Topics: Acetates; Adenine Nucleotides; Amides; Barbiturates; Chloroquine; Enzyme Inhibitors; Hexachlorocyclo | 1964 |
[A CASE OF PORPHYRIA CONGENITA].
Topics: Child; Chloroquine; Corrinoids; Drug Therapy; Humans; Pathology; Porphyria, Erythropoietic; Porphyri | 1964 |
[THERAPEUTIC EXPERIENCES WITH RESOCHIN AND RESOCHIN-CONTAINING PREPARATIONS IN DERMATOLOGICAL PATIENTS].
Topics: Carcinoma, Squamous Cell; Chloroquine; Drug Eruptions; Drug Therapy; Finger Injuries; Hematoma; Herp | 1964 |
EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.
Topics: Amino Acids; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Chloroquine; Class | 1965 |
[Morphology of liver damage in chronic hepatic porphyria with special reference to the effect of therapy].
Topics: Adult; Aged; Biopsy; Bloodletting; Chloroquine; Female; Humans; Inclusion Bodies; Liver; Liver Disea | 1984 |
Porphyria variegata: failure of chloroquin treatment.
Topics: Adult; Chloroquine; Female; Humans; Porphyrias; Porphyrins; Skin Diseases | 1980 |
[Porphyria cutanea tarda (PCT)].
Topics: Bloodletting; Chloroquine; Diagnosis, Differential; Female; Humans; Liver Diseases; Male; Porphyrias | 1983 |
Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
Topics: Administration, Oral; Adult; Aged; Chloroquine; Drug Administration Schedule; Humans; Male; Middle A | 1984 |
[Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
Topics: Chloroquine; Humans; Porphyrias; Skin Diseases | 1984 |
[Porphyria cutanea tarda and chronic lymphatic leukemia].
Topics: Bloodletting; Chloroquine; Combined Modality Therapy; Humans; Leukemia, Lymphoid; Lymph Nodes; Male; | 1984 |
[Immunological aspects of porphyria cutanea tarda].
Topics: Adult; Aged; Chloroquine; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Porphyrias; Rose | 1983 |
[Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
Topics: Chloroquine; Female; Humans; Hypertrichosis; Middle Aged; Porphyrias; Skin Diseases; Uroporphyrins | 1983 |
Studies on in vitro formation of complexes between porphyrins and chloroquine.
Topics: Chloroquine; Chromatography, Gel; Humans; Porphyrias; Porphyrins; Skin Diseases; Spectrophotometry; | 1983 |
[Delagil treatment of urocoproporphyria].
Topics: Adult; Chloroquine; Coproporphyrins; Drug Evaluation; Edetic Acid; Female; Humans; Inosine; Male; Mi | 1980 |
Porphyria cutanea tarda and pregnancy.
Topics: Adult; Chloroquine; Female; Humans; Porphyrias; Porphyrins; Pregnancy; Pregnancy Complications; Skin | 1983 |
Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
Topics: Adult; Aged; Bloodletting; Chloroquine; Female; Follow-Up Studies; Humans; Liver; Male; Middle Aged; | 1982 |
[Effect of chloroquine in porphyria cutanea tarda].
Topics: Adult; Aged; Alcohol Drinking; Chloroquine; Coproporphyrins; Humans; Liver Function Tests; Male; Mid | 1980 |
[The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria].
Topics: Adult; Aged; Chloroquine; Humans; Liver; Liver Diseases; Middle Aged; Porphyrias | 1982 |
The liver in Ethiopians with porphyria cutanea tarda.
Topics: Adult; Aged; Alcohol Drinking; Biopsy; Chloroquine; Ethiopia; Female; Humans; Inflammation; Liver; L | 1982 |
Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
Topics: Adult; Chloroquine; Dose-Response Relationship, Drug; Humans; Liver Diseases; Male; Middle Aged; Por | 1981 |
Porphyria Cutanea tarda in Missouri.
Topics: Chloroquine; Humans; Porphyrias; Skin Diseases | 1981 |
[Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
Topics: Adult; Chloroquine; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Porphyrias; Skin Di | 1981 |
Chloroquine in the treatment of porphyria cutanea tarda.
Topics: Adult; Aged; Chloroquine; Female; Humans; Male; Middle Aged; Porphyrias; Porphyrins; Skin Diseases | 1981 |
[Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chloroquine; Female; Humans; Infant; Liver Disease | 1981 |
[Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
Topics: Adult; Aged; Animals; Chloroquine; Female; Humans; Liver Diseases; Male; Middle Aged; Porphyrias; Po | 1981 |
Immunological and biochemical findings in patients with porphyria cutanea tarda.
Topics: Adult; Aged; Chloroquine; Complement System Proteins; Female; Humans; Immunoglobulin G; Male; Middle | 1981 |
Liver changes in porphyria cutanea tarda patients treated with chloroquine.
Topics: Adult; Aged; Chloroquine; Female; Humans; Liver; Male; Middle Aged; Porphyrias; Skin Diseases | 1980 |
[Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].
Topics: Animals; Chloroquine; Female; Hexachlorobenzene; Iron; Liver; Porphyrias; Porphyrins; Rats; Skin | 1980 |
[Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
Topics: Adult; Aged; Bloodletting; Chloroquine; Female; Humans; Liver; Male; Middle Aged; Porphyrias | 1980 |
[Acute intermittent porphyria detected during treatment of malaria with chloroquine].
Topics: Acute Disease; Adult; Chloroquine; Diagnosis, Differential; Diagnostic Errors; Humans; Malaria; Male | 1980 |
[Treatment of porphyria cutanea tarda with intermittent chloroquine].
Topics: Chloroquine; Drug Administration Schedule; Female; Humans; Male; Porphyrias; Porphyrins; Skin Diseas | 1980 |
[Modern internal therapy of skin diseases (author's transl)].
Topics: Anti-Inflammatory Agents; Carotenoids; Chloroquine; Cyclooxygenase Inhibitors; Glucocorticoids; Huma | 1979 |
[Porphyria cutanea tarda: possible treatment and its results (author's transl)].
Topics: 4-Aminobenzoic Acid; Bloodletting; Chloroquine; Female; Humans; Male; Porphyrias; Porphyrins; Time F | 1978 |
Management of porphyria cutanea tarda.
Topics: Aged; Chloroquine; Female; Humans; Porphyrias; Skin Diseases, Vesiculobullous | 1977 |
Porphyria cutanea tarda: clinical and laboratory features.
Topics: Adult; Aged; Aspartate Aminotransferases; Bloodletting; Chloroquine; Estrogens; Ethanol; Female; Fer | 1979 |
Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.
Topics: Adult; Aged; Alcohol Drinking; Bloodletting; Child; Chloroquine; Contraceptives, Oral; Diabetes Comp | 1979 |
[Clinic and treatment of porphyria cutanea tarda (author's transl)].
Topics: Bloodletting; Chloroquine; Female; Humans; Male; Porphyrias | 1979 |
[Porphyria cutanea tarda].
Topics: Adult; Aged; Bloodletting; Chloroquine; Diagnosis, Differential; Female; Humans; Hypertrichosis; Liv | 1979 |
[Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
Topics: Adult; Aged; Chloroquine; Drug Tolerance; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; | 1977 |
Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine.
Topics: Aged; Chloroquine; Drug Administration Schedule; Humans; Male; Photosensitivity Disorders; Porphyria | 1978 |
[Therapy of porphyria cutanea tarda using chloroquine].
Topics: Adult; Chloroquine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Porphyrias; Rem | 1978 |
[Porphyria erythropoietica congenita Günther and chloroquine (author's transl)].
Topics: Child; Chloroquine; Elasticity; Erythrocytes; Erythropoiesis; Humans; Male; Photosensitivity Disorde | 1978 |
Porphyria variegata. Study of a large kindred in the United States.
Topics: Adolescent; Adult; Aged; Child; Chloroquine; Coproporphyrins; Feces; Female; Humans; Male; Middle Ag | 1978 |
Chloroquine in the treatment of porphyria cutanea tarda. Case report.
Topics: Aged; Chloroquine; Female; Humans; Porphyrias | 1977 |
Chloroquine in the treatment of porphyria cutanea tarda.
Topics: Chloroquine; Humans; Porphyrias; Remission, Spontaneous; Time Factors | 1977 |
Study of the effects of certain drugs on experimental porphyria in rats.
Topics: Animals; Chloroquine; Dicarbethoxydihydrocollidine; Ethanol; Griseofulvin; Liver; Phenobarbital; Por | 1977 |
[Effect of chloroquine on porphyrin transport in serum and liver cells (author's transl)].
Topics: Adult; Binding Sites; Biological Transport; Chloroquine; Humans; Liver; Middle Aged; Porphyrias; Por | 1977 |
The treatment of cutaneous porphyria.
Topics: Chloroquine; Humans; Penicillamine; Porphyrias | 1977 |
Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
Topics: Adult; Aged; Bloodletting; Chloroquine; Female; Humans; Male; Middle Aged; Porphyrias; Porphyrins | 1977 |
An unusual reaction to chloroquine-primaquine.
Topics: Adult; Chloroquine; Coproporphyrins; Female; Humans; Malaria; Porphyrias; Primaquine; Uroporphyrins | 1976 |
[Hydroa vacciniforme Bazin].
Topics: Adolescent; Adult; Amino Acids; Antimalarials; Carotenoids; Child; Child, Preschool; Chloroquine; Di | 1975 |
Letter: Retreatment with chloroquine in porphyria cutanea tarda.
Topics: Administration, Oral; Chloroquine; Humans; Porphyrias; Recurrence | 1975 |
[Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].
Topics: Aminolevulinic Acid; Chloroquine; Humans; Liver; Male; Medication Errors; Middle Aged; Mitochondria, | 1976 |
Effective control of patients with porphyria cutanea tarda by measuring plasma uroporphyrin.
Topics: Adult; Aged; Aged, 80 and over; Bloodletting; Chloroquine; Female; Humans; Male; Middle Aged; Porphy | 1991 |
Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.
Topics: Adult; Chloroquine; Female; Humans; Male; Middle Aged; Porphyrias; Remission Induction; Skin; Skin D | 1991 |
[Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Female; Humans; Iron; Male; Porphyrias; | 1990 |
Porphyria cutanea tarda due to ferrous gluconate.
Topics: Aged; Chloroquine; Female; Ferrous Compounds; Humans; Porphyrias; Porphyrins | 1990 |
[Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
Topics: Administration, Oral; Adult; Aged; Bloodletting; Chloroquine; Combined Modality Therapy; Dose-Respon | 1990 |
[Artefacts in porphyria cutanea tarda].
Topics: Bloodletting; Chloroquine; Combined Modality Therapy; Diagnosis, Differential; Humans; Male; Malinge | 1990 |
[Porphyria cutanea tarda and lupus erythematosus].
Topics: Adult; Biopsy; Chloroquine; Cyclophosphamide; Humans; Kidney; Liver; Liver Function Tests; Lupus Ery | 1989 |
[Experimental study of the action of antimalarial agents with respect to therapy in porphyria. Combined effect of chloroquine and pyrimethamine].
Topics: Chloroquine; Humans; Porphyrias; Porphyrins; Pyrimethamine; Saccharomyces cerevisiae | 1989 |
[Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
Topics: Alcoholism; Chloroquine; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Admi | 1986 |
[2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
Topics: Adult; Chloroquine; Drug Therapy, Combination; Female; Humans; Liver Diseases; Male; Middle Aged; Po | 1988 |
Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
Topics: Adult; Aged; Chloroquine; Ethiopia; Female; Humans; Liver; Male; Middle Aged; Porphyrias; Skin Disea | 1987 |
The porphyrias.
Topics: Adolescent; Adult; Aminolevulinic Acid; beta Carotene; Bloodletting; Carotenoids; Child; Child, Pres | 1986 |
Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
Topics: Child; Chloroquine; Female; Humans; Male; Porphyrias; Porphyrins; S-Adenosylmethionine; Skin Disease | 1987 |
[Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda].
Topics: Adult; Chloroquine; Dose-Response Relationship, Drug; Female; Humans; Liver; Medication Errors; Porp | 1986 |
Effects of chloroquine and hydroxychloroquine on the hexachlorobenzene-induced porphyria in rats.
Topics: Animals; Chlorobenzenes; Chloroquine; Female; Hexachlorobenzene; Hydroxychloroquine; Porphyrias; Rat | 1986 |
Porphyria cutanea tarda simulating scleroderma.
Topics: Chloroquine; Diagnosis, Differential; Female; Humans; Middle Aged; Porphyrias; Scleroderma, Systemic | 1987 |
Treatment of chronic hepatic porphyria (PCT).
Topics: Bloodletting; Chloroquine; Humans; Hydroxychloroquine; Liver Diseases; Porphyrias | 1986 |
Treatment of porphyria cutanea tarda.
Topics: Chloroquine; Humans; Porphyrias; Skin Diseases | 1987 |
[Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine].
Topics: Adult; Aged; Chloroquine; Drug Therapy, Combination; Humans; Liver Diseases; Male; Middle Aged; Porp | 1987 |
Porphyria cutanea tarda symptomatica.
Topics: Adolescent; Chloroquine; Female; Humans; Porphyrias; Porphyrins; Skin Diseases | 1985 |
Influence of chloroquine on the porphyrin metabolism.
Topics: 7-Alkoxycoumarin O-Dealkylase; Aminolevulinic Acid; Aminopyrine N-Demethylase; Animals; Aryl Hydroca | 1985 |
Porphyria cutanea tarda symptomatica in children treated with chloroquine. Report of four cases with control liver biopsies.
Topics: Adolescent; Child; Chloroquine; Humans; Liver; Male; Porphyrias; Skin Diseases | 1985 |
Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda.
Topics: Aged; beta Carotene; Carotenoids; Chloroquine; Complement Activation; Complement C3; Complement Syst | 1985 |
Proceedings: Porphyria cutanea tarda.
Topics: Adult; Chloroquine; Female; Humans; Porphyrias; Skin Diseases | 1974 |
Peripheral clinical laboratory service for the Border and Transkei.
Topics: Afibrinogenemia; Amebiasis; Balantidiasis; Black or African American; Black People; Cantharidin; Chi | 1973 |
[A case of chloroquine-induced porphyrinuria].
Topics: Acute Disease; Arthritis, Rheumatoid; Chloroquine; Female; Humans; Middle Aged; Porphyrias; Porphyri | 1973 |
Incorporation of (4-14 C) -aminolaevulinate into urinary porphyrins in porphyria cutanea tarda: effect of chloroquine therapy.
Topics: Adult; Aged; Autopsy; Carbon Isotopes; Carboxylic Acids; Chloroquine; Decarboxylation; Feces; Humans | 1973 |
[Therapy of patients with porphyria cutanea tarda with antimalarials].
Topics: Adult; Aged; Chloroquine; Female; Humans; Male; Middle Aged; Porphyrias; Time Factors; Transaminases | 1973 |
The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda.
Topics: Alanine Transaminase; Chloroquine; Female; Humans; Liver; Middle Aged; Mitochondria, Liver; Porphyri | 1973 |
The molecular basis of the action of chloroquine in porphyria cutanea tarda.
Topics: 5-Aminolevulinate Synthetase; Animals; Chemical Phenomena; Chemistry; Chloroquine; Chromatography, G | 1973 |
Treatment of porphyria cutanea tarda with chloroquine.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Chloroquine; F | 1974 |
Current concepts of cutaneous porphyria and its treatment with particular reference to the use of sodium calciumedetate.
Topics: Australia; Barbiturates; Chloroquine; Cholestyramine Resin; Diet Therapy; Edetic Acid; Estrogens; Gr | 1970 |
Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
Topics: Adult; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chloroquine; Deferoxamine; Humans | 1972 |
[Chloroquine therapy in porphyria cutanea tarda].
Topics: Aged; Bloodletting; Chloroquine; Eosinophilia; Female; Humans; Male; Middle Aged; Porphyrias; Porphy | 1971 |
Evaluation of therapy in acquired porphyria cutanea tarda.
Topics: Adenosine Monophosphate; Adult; Chelating Agents; Chloroquine; Humans; Porphyrias; Pyridoxal Phospha | 1971 |
Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
Topics: Ascites; Body Temperature; Chemical and Drug Induced Liver Injury; Chloroquine; Chromatography; Fece | 1970 |
Porphyria cutanea tarda.
Topics: Adult; Chloroquine; Humans; Male; Porphyrias; Porphyrins | 1970 |
The treatment of cutaneous porphyria with chloroquine or D-penicillamine.
Topics: Chloroquine; Humans; Penicillamine; Porphyrias; Porphyrins | 1970 |
Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
Topics: Aged; Chloroquine; Feces; Female; Humans; Male; Porphyrias; Porphyrins; Pregnancy; Pregnancy Complic | 1968 |
Porphyria cutanea tarda treated with chloroquine phosphate.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chloroquine; Humans; Male; Middle Aged; Porphyria | 1969 |
Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.
Topics: Adult; Aged; Chloroquine; Humans; Liver; Middle Aged; Porphyrias; Porphyrins; Skin Manifestations | 1966 |